Elizabeth Coker
Elizabeth Coker
Wellcome Sanger Institute, Cambridge
Verified email at sanger.ac.uk
Title
Cited by
Cited by
Year
canSAR: updated cancer research and drug discovery knowledgebase
KC Bulusu, JE Tym, EA Coker, AC Schierz, B Al-Lazikani
Nucleic acids research 42 (D1), D1040-D1047, 2014
832014
canSAR: an updated cancer research and drug discovery knowledgebase
JE Tym, C Mitsopoulos, EA Coker, P Razaz, AC Schierz, AA Antolin, ...
Nucleic acids research 44 (D1), D938-D943, 2016
792016
canSAR: update to the cancer translational research and drug discovery knowledgebase
EA Coker, C Mitsopoulos, JE Tym, A Komianou, C Kannas, P Di Micco, ...
Nucleic acids research 47 (D1), D917-D922, 2019
192019
Differences in signaling patterns on PI3K inhibition reveal context specificity in KRAS-mutant cancers
A Stewart, EA Coker, S P÷lsterl, A Georgiou, AR Minchom, S Carreira, ...
Molecular cancer therapeutics 18 (8), 1396-1404, 2019
72019
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens
E Goncalves, A Segura-Cabrera, C Pacini, G Picco, F Behan, P Jaaks, ...
bioRxiv, 2020
62020
SiGNet: A signaling network data simulator to enable signaling network inference
EA Coker, C Mitsopoulos, P Workman, B Al-Lazikani
Plos one 12 (5), e0177701, 2017
42017
Leveraging human genetics to guide cancer drug development
B Kinnersley, A Sud, EA Coker, JE Tym, P Di Micco, B Al-Lazikani, ...
JCO Clinical Cancer Informatics 2, 1-11, 2018
22018
Simulated ablation for detection of cells impacting paracrine signalling in histology analysis
JP Taylor–King, E Baratchart, A Dhawan, EA Coker, IH Rye, H Russnes, ...
Mathematical medicine and biology: a journal of the IMA 36 (1), 93-112, 2019
12019
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia
SB Balachander, SW Criscione, KF Byth, J Cidado, A Adam, P Lewis, ...
Clinical Cancer Research, 2020
2020
Abstract C007: A high-throughput screen to identify effective and translationally-relevant drug combinations for breast, colorectal, and pancreatic cancers
EA Coker, P Jaaks, DJ Vis, N Aben, S Barthorpe, D van der Meer, ...
Molecular Cancer Therapeutics 18 (12 Supplement), C007-C007, 2019
2019
A high-throughput screen to identify effective and translationally-relevant drug combinations for breast, colorectal, and pancreatic cancers
EA Coker, P Jaaks, DJ Vis, N Aben, S Barthorpe, D van der Meer, ...
MOLECULAR CANCER THERAPEUTICS 18 (12), 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–11